EU health security planning prioritises protective equipment
Europe faces rising threats from pandemics, armed conflicts, chemical, biological and radiological exposure and nuclear (CBRN) attacks, and PPE is now viewed as critical not only for healthcare professionals, but also for care home staff, civil protection teams and humanitarian workers.
Commissioner for Equality, Preparedness and Crisis Management, Hadja Lahbib, said, 'We know the threats we face. And we know we can handle them. Hybrid attacks, power blackouts, extreme weather, and spreading diseases. These are no longer distant risks. That is why we are moving preparedness from the sidelines to the frontline of our defence.'
The Preparedness Strategy, adopted in March 2025, reflects this shift toward resilience, placing PPE on equal footing with vaccines and diagnostics. It also introduces preparedness roadmaps, a priority list of medical countermeasures, and sentinel systems like wastewater monitoring.
To support rapid deployment, the Commission is reinforcing its industrial base through EU FAB's ever-warm production and the new RAMP UP partnership.
From strategy to action
The Stockpiling Strategy establishes an EU network to coordinate reserves across Member States, improve visibility, reduce duplication, and guide joint recommendations.
In a statement to Euractiv, 3M welcomed stronger EU coordination on health preparedness.
'The two EU strategies underscore the critical importance of Personal Protective Equipment (PPE) in safeguarding frontline workers and the general population,' said Maxime Bureau, 3M Director of EU Government Affairs.
'The EU Stockpiling Network shows the EU's commitment to enhancing coordination among EU countries, ensuring transparency in the management and procurement of critical medical countermeasures, including PPE. As we move forward, it is essential to centralise actions at EU level to ensure a unified and efficient response to health emergencies, leveraging collective resources and expertise for the benefit of all Member States,' said Bureau.
The Commission expects this network to map national reserves, including their locations, contents and management, to improve coordination and crisis response.
Strengthening EU PPE reserves
As part of its wider preparedness push, the EU is expanding rescEU, originally created for wildfire response, to include pandemics and CBRN threats.
'One lesson learnt from the COVID-19 pandemic was the importance of developing and sustaining comprehensive medical stockpiles.'
These reserves now cover PPE, vaccines, medical devices and countermeasures for threats like zoonotic diseases and burns.
To improve sustainability, the EU is testing virtual stockpiling and vendor-based models to reduce waste and ensure access without constant replenishment.
In emergencies, rescEU allows direct or joint procurement and can cover up to 100% of transport costs.
Mobilising partnerships
The strategy also promotes public-private and civil-military partnerships to streamline logistics and supply chains. These collaborative models are seen as critical to delivering PPE and other stockpiled goods effectively during crises. This includes enhanced logistics and a fresh supply chain assessment for countermeasures not on the Union's critical medicines list, such as PPE or diagnostics.
'We will work with European companies in every Member State to make sure essential supplies, like food, water, medicines, masks, and testing kits, are ready when we need them,' said Commissioner Lahbib.
Driving innovation, preparedness
To improve readiness, HERA will continue to lead emergency procurement, manufacturing and R&D.
Its 2026 Medifence initiative aims to stockpile reusable PPE and support innovation in biosensors and drug platforms.
Meanwhile, the Medical Countermeasures Accelerator will help close innovation gaps in PPE, diagnostics, vaccines and treatments, offering regulatory and financial support.
HERA is also piloting a shelf-life extension scheme to reduce PPE waste.
Together, HERA and the Accelerator show the EU's broader shift from stockpiling alone to long-term innovation and preparedness.
The pandemic demonstrated the need for consistent funding. In response, the Commission has allocated over €5 billion from 2021–2027 via EU4Health, Horizon Europe and rescEU. Future funding will be debated during the next EU budget round.
MEP Nicolás González Casares warned that funding must match ambition.
'The truth is that the EU relies heavily on imports from China for much of its required PPE,' he said. 'While Horizon Europe and EU4Health can support R&D for more sustainable and scalable PPE, there should be European-specific funds for these needs. Otherwise, we risk diverting investment away from medical needs that are no less important.'
He called for financial tools to ensure both rapid response and long-term security.
'We have been discussing how to reinforce Europe's security strategy. Let's allocate targeted funds for the short-term and long-term reinforcement of strategic supply resources.'
Leaving no one behind
Equity is central to the EU's PPE strategy. González Casares stressed that distribution must go beyond hospitals, saying: 'There are two levels at which this issue is addressed: one related to ordinary shortages and the other related to crisis management'
'Obviously, the supply strategy must address both needs, as well as distribution. Not only is direct healthcare at hospitals a need, but so are other things. Care homes, humanitarian actors, and civil protection teams must also be covered.'
This reflects the Commission's commitment to ensuring shared EU resources benefit all Member States.
Looking ahead, the success of both strategies will hinge on implementation.
Key milestones now include the operational launch of the EU Stockpiling Network, deployment of the Medical Countermeasures Accelerator, and upcoming initiatives like Medifence in 2026.
With funding discussions tied to the next Multiannual Financial Framework, the coming weeks will be crucial to ensure the EU's ambition for strategic autonomy and crisis resilience translates into concrete preparedness on the ground.
[Edited By Brian Maguire | Euractiv's Advocacy Lab ]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euractiv
4 days ago
- Euractiv
EU must take lead role on pharma, and patient access, says Czech minister
Czech Deputy Health Minister Michaela Matoušková (STAN, EPP) is calling for stronger EU action on pharmaceutical policy, better coordination on digital health, and a more unified approach to patient access to innovative medicines across the bloc. In an interview with Euractiv, Matoušková urged the EU to move from passive coordination to proactive support, particularly when it comes to ensuring equitable access to innovative medicines and building the Union's strategic autonomy in healthcare. Matoušková, who took office in February this year, believes the COVID-19 pandemic and the EU's fragmented response exposed structural weaknesses that Brussels now has an opportunity to address. 'We have the brains, but we lack coordination – and that is the role of the European Union,' she said. She argues that the EU level is the only viable arena to tackle the uneven and delayed access to new medicines that persists across member states. 'Some smaller states do not introduce medicines, even though the European Medicines Agency (EMA) has approved them, as quickly as others. If we really want a patient-focused approach, this has to change,' she said. The Czech deputy minister voiced strong support for the pharmaceutical package currently negotiated by EU institutions in the trilogues. However, she underlined that success will depend on finding the right balance between patient access, price and industry incentives. 'The compromise is crucial,' she said. She noted that the Commission's proposal rightly aims to increase access to medicines in all member states, but that this will require cooperation from industry. 'They need to understand what we are trying to achieve: speed of rollout and availability,' Matoušková said. Innovation vouchers One of her concerns is the growing trend of pharmaceutical companies threatening to pull out of Europe in response to proposed changes in market exclusivity rules. 'The USA invests significantly more – three times more than the EU, I believe. But it's not just about money. It's about how fast we bring medicines to market and how long the data and market protection lasts,' she said. Matoušková acknowledged the financial pressures innovators face and expressed support for maintaining incentives that allow for returns on investment. To bridge the interests of both patients and industry, she supported 'a system of innovation vouchers' as a complementary tool to support faster development and approval of new drugs, while maintaining investment appeal. She also addressed the broader relationship between innovation and generics, noting, 'I think generics will always be here. But we need to push for innovation, that is what we need to protect.' Matoušková also sees digital health as an area where EU leadership is urgently needed. While the European Health Data Space regulation has opened a promising debate, the deputy minister warns that implementation is lagging in some areas. 'We would like to have shared medical documentation, but we are missing regional data networks. We do not have enough infrastructure to make it work,' said Matoušková. She believes the EU should step in with funding and coordination. 'The EU should provide the legal framework, the conditions, and the funding. The EU should be the roof over the whole structure,' she said. Cross-border cooperation Her ambition is also to see greater EU involvement in cross-border emergency services. 'Why do we need bilateral treaties for cross-border emergency care? We could define it at the EU level,' she said. In the longer term, Matoušková urges Brussels to invest in services that reflect demographic changes and make a difference on the ground, such as palliative care and home-based support for older people. 'Personally, I am not a fan of building more facilities. Care should move closer to patients, into the field, into their homes,' she said. She would also welcome more EU guidance on workforce reform, including a broader debate on prescription rights for qualified non-physician personnel, adding that, 'We have very erudite non-physician professionals in Czechia, but they haven't been granted the appropriate competences.' Her message to EU policymakers is clear: health policy must be treated as a strategic investment. 'We should see the EU not as a repressive body, but as a source of change – an institution that supports innovation. Not as a dictator, but as a partner that helps address our needs,' she said. [Edited by Vasiliki Angouridi, Brian Maguire]
Euractiv
4 days ago
- Euractiv
Bulgaria's telemedicine proposal sparks backlash over state monopoly
The Bulgarian government is facing strong criticism from legal experts and medical professionals over a draft regulation that aims to formalise telemedicine but limits its development by mandating the use of a single, state-run communication platform. In late June, the Bulgarian health ministry unveiled a draft ordinance to regulate remote medical services in the country. Instead of garnering support, the proposal drew fierce opposition from doctors, patients, and legal experts, who argue that the regulation introduces technical and organisational requirements that are nearly impossible to fulfil. Under the proposed rules, all remote consultations between patients and doctors, or between medical professionals, would have to be conducted exclusively through the National Health Information System (NHIS), a state-run digital infrastructure. According to Velichka Kostadinova, a lawyer specialised in medical law, this creates a de facto monopoly that could violate EU internal market rules. 'Requiring telemedicine to function solely via the state system contradicts EU legislation because it restricts competition and the free movement of services,' Kostadinova told Euractiv. Low quality and high cost concerns Kostadinova cited EU Court of Justice case law classifying medical services under Article 57 of the Treaty on the Functioning of the European Union, which guarantees the freedom to provide services across the bloc. 'If the system crashes, there's no alternative. That means a complete shutdown of telemedicine, which could also disrupt cross-border cooperation in the EU, especially in light of the upcoming MyHealth@EU platform,' she warned. Critics argue that such centralisation will stifle innovation and lead to reduced quality of care. 'Instead of making access to healthcare easier, we are effectively blocking it,' said Kostadinova. 'We risk reaching the absurd point where doctors can't communicate with their patients-not by phone, not through secure electronic platforms.' Senior officials from Sofia-based hospitals, speaking on condition of anonymity, told Euractiv that the technical requirements proposed by the state would be prohibitively expensive. Hospitals would be required to set up private, offline computer networks and ensure secure data storage across two physically distant servers. While larger hospitals may be able to shoulder the investment, these conditions are deemed unworkable for doctors in private practice. 'No general practitioner can meet these demands unless they have a bunker filled with advanced tech,' said one Sofia-based GP. 'This goes beyond what is reasonable,' she said. The draft does include some positive provisions, such as mandatory informed consent from patients and a clear list of medical procedures that cannot be performed remotely, like surgery or the declaration of death. Legal challenges and obscurities However, the requirement to use only one communication platform is not stipulated in law, Kostadinova noted. The health minister has the authority to define technical standards for remote care, but not to mandate a single channel for its provision. This opens the door for a potential legal challenge to the ordinance. Despite the growing role of digital technology in healthcare, the proposed regulation seems to add barriers rather than removing them, observers say. Other EU countries, including France, Germany, Sweden, Greece, and Romania, allow the use of multiple certified platforms, provided they meet national legal requirements. Authorisation procedures in these countries vary depending on whether the platform employs doctors or simply connects them with patients, and whether services are reimbursed by national health insurance or paid out-of-pocket. But no other EU country has imposed a single-channel restriction. 'There's still no clarity in Bulgaria on who will pay for telemedicine, how, and when,' Kostadinova said. Tanya Andreeva, a paediatric rheumatologist, told Euractiv that current practice makes even basic online communication between doctors and patients legally dubious. 'I'm not even talking about telemedicine platforms. Patients can't send me a blood test over Viber. If I try to help without charging them, I'm breaking the rules,' Andreeva said. 'If someone checks my phone, filled with images of children's rashes and lab results, I could be accused of being the country's biggest violator.' Health ministry reaction In its defence, the health ministry argues that the regulation aims to establish clear rules and align the quality standards of remote medical care with those of in-person treatment. 'Given the rising role of telemedicine, this is a timely step to harmonise with EU trends and WHO recommendations,' the ministry said in the explanatory note to the draft ordinance. While the EU has not yet adopted binding rules on telemedicine, the European Commission and the World Health Organisation have long recognised its strategic importance. Since the Commission's 2008 Communication on telemedicine and in its more recent 'Digital Compass 2030' strategy, remote healthcare has been framed as a pillar of accessible and sustainable health systems. The health ministry maintains that its proposal follows guidelines by focusing on universal access, safety, and equality of care. However, critics say the country risks falling behind its EU peers in realising the full potential of telemedicine. [Edited by Vasiliki Angouridi, Brian Maguire]
Euractiv
6 days ago
- Euractiv
EU health security planning prioritises protective equipment
The EU is putting personal protective equipment (PPE) at the heart of its health security strategy. With the launch of its first-ever Stockpiling Strategy and Medical Countermeasures Strategy, the European Commission aims to ensure swift access to PPE and other essential tools to protect workers and citizens in future crises. Europe faces rising threats from pandemics, armed conflicts, chemical, biological and radiological exposure and nuclear (CBRN) attacks, and PPE is now viewed as critical not only for healthcare professionals, but also for care home staff, civil protection teams and humanitarian workers. Commissioner for Equality, Preparedness and Crisis Management, Hadja Lahbib, said, 'We know the threats we face. And we know we can handle them. Hybrid attacks, power blackouts, extreme weather, and spreading diseases. These are no longer distant risks. That is why we are moving preparedness from the sidelines to the frontline of our defence.' The Preparedness Strategy, adopted in March 2025, reflects this shift toward resilience, placing PPE on equal footing with vaccines and diagnostics. It also introduces preparedness roadmaps, a priority list of medical countermeasures, and sentinel systems like wastewater monitoring. To support rapid deployment, the Commission is reinforcing its industrial base through EU FAB's ever-warm production and the new RAMP UP partnership. From strategy to action The Stockpiling Strategy establishes an EU network to coordinate reserves across Member States, improve visibility, reduce duplication, and guide joint recommendations. In a statement to Euractiv, 3M welcomed stronger EU coordination on health preparedness. 'The two EU strategies underscore the critical importance of Personal Protective Equipment (PPE) in safeguarding frontline workers and the general population,' said Maxime Bureau, 3M Director of EU Government Affairs. 'The EU Stockpiling Network shows the EU's commitment to enhancing coordination among EU countries, ensuring transparency in the management and procurement of critical medical countermeasures, including PPE. As we move forward, it is essential to centralise actions at EU level to ensure a unified and efficient response to health emergencies, leveraging collective resources and expertise for the benefit of all Member States,' said Bureau. The Commission expects this network to map national reserves, including their locations, contents and management, to improve coordination and crisis response. Strengthening EU PPE reserves As part of its wider preparedness push, the EU is expanding rescEU, originally created for wildfire response, to include pandemics and CBRN threats. 'One lesson learnt from the COVID-19 pandemic was the importance of developing and sustaining comprehensive medical stockpiles.' These reserves now cover PPE, vaccines, medical devices and countermeasures for threats like zoonotic diseases and burns. To improve sustainability, the EU is testing virtual stockpiling and vendor-based models to reduce waste and ensure access without constant replenishment. In emergencies, rescEU allows direct or joint procurement and can cover up to 100% of transport costs. Mobilising partnerships The strategy also promotes public-private and civil-military partnerships to streamline logistics and supply chains. These collaborative models are seen as critical to delivering PPE and other stockpiled goods effectively during crises. This includes enhanced logistics and a fresh supply chain assessment for countermeasures not on the Union's critical medicines list, such as PPE or diagnostics. 'We will work with European companies in every Member State to make sure essential supplies, like food, water, medicines, masks, and testing kits, are ready when we need them,' said Commissioner Lahbib. Driving innovation, preparedness To improve readiness, HERA will continue to lead emergency procurement, manufacturing and R&D. Its 2026 Medifence initiative aims to stockpile reusable PPE and support innovation in biosensors and drug platforms. Meanwhile, the Medical Countermeasures Accelerator will help close innovation gaps in PPE, diagnostics, vaccines and treatments, offering regulatory and financial support. HERA is also piloting a shelf-life extension scheme to reduce PPE waste. Together, HERA and the Accelerator show the EU's broader shift from stockpiling alone to long-term innovation and preparedness. The pandemic demonstrated the need for consistent funding. In response, the Commission has allocated over €5 billion from 2021–2027 via EU4Health, Horizon Europe and rescEU. Future funding will be debated during the next EU budget round. MEP Nicolás González Casares warned that funding must match ambition. 'The truth is that the EU relies heavily on imports from China for much of its required PPE,' he said. 'While Horizon Europe and EU4Health can support R&D for more sustainable and scalable PPE, there should be European-specific funds for these needs. Otherwise, we risk diverting investment away from medical needs that are no less important.' He called for financial tools to ensure both rapid response and long-term security. 'We have been discussing how to reinforce Europe's security strategy. Let's allocate targeted funds for the short-term and long-term reinforcement of strategic supply resources.' Leaving no one behind Equity is central to the EU's PPE strategy. González Casares stressed that distribution must go beyond hospitals, saying: 'There are two levels at which this issue is addressed: one related to ordinary shortages and the other related to crisis management' 'Obviously, the supply strategy must address both needs, as well as distribution. Not only is direct healthcare at hospitals a need, but so are other things. Care homes, humanitarian actors, and civil protection teams must also be covered.' This reflects the Commission's commitment to ensuring shared EU resources benefit all Member States. Looking ahead, the success of both strategies will hinge on implementation. Key milestones now include the operational launch of the EU Stockpiling Network, deployment of the Medical Countermeasures Accelerator, and upcoming initiatives like Medifence in 2026. With funding discussions tied to the next Multiannual Financial Framework, the coming weeks will be crucial to ensure the EU's ambition for strategic autonomy and crisis resilience translates into concrete preparedness on the ground. [Edited By Brian Maguire | Euractiv's Advocacy Lab ]
